Combining Galantamine and Memantine for Parkinson's Disease Dementia
Author Information
Author(s): Frost Emma D., Shi Swanny X., Byroju Vishnu V., Pitton Rissardo Jamir, Donlon Jack, Vigilante Nicholas, Murray Briana P., Walker Ian M., McGarry Andrew, Ferraro Thomas N., Hanafy Khalid A., Echeverria Valentina, Mitrev Ludmil, Kling Mitchel A., Krishnaiah Balaji, Lovejoy David B., Rahman Shafiqur, Stone Trevor W., Koola Maju Mathew
Primary Institution: Cooper Neurological Institute, Cooper University Health Care, Camden, NJ, USA
Hypothesis
Can the combination of galantamine and memantine improve cognitive function in patients with Parkinson's disease dementia?
Conclusion
The combination of galantamine and memantine shows promise in enhancing cognitive function in patients with Parkinson's disease dementia.
Supporting Evidence
- The combination of galantamine and memantine targets multiple neurotransmitter pathways.
- Preclinical studies indicate a synergistic effect on cognitive enhancement.
- Current treatments for Parkinson's disease dementia are limited and often ineffective.
Takeaway
This study suggests that using two medications together might help people with memory problems caused by Parkinson's disease.
Methodology
The review summarizes existing research on the effects of galantamine and memantine on cognitive function in Parkinson's disease dementia.
Limitations
The combination has not yet been studied in randomized controlled trials specifically for Parkinson's disease dementia.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website